UCB BIOPHARMA

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "old": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "changed": false
  }
}

{
  "notary": {
    "name": "Matthieu DERYNCK",
    "firm_city": null,
    "firm_name": "Van Halteren Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2026-01-02",
    "filing_date": "2025-12-30",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-04-28",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "translation_only",
    "trigger": "wvv_adaptation",
    "language_after": "fr",
    "language_before": "fr"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full_after": "UCB BIOPHARMA",
    "legal_form_after": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "name_full_before": "UCB BIOPHARMA",
    "current_zetel_raw": "All\u00E9e de la Recherche 60, 1070 Anderlecht",
    "legal_form_before": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "Van Halteren Notaires",
      "scope_categories": [
        "publication"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "Article 5 des statuts est modifi\u00E9 pour refl\u00E9ter le montant d\u00E9finitif des capitaux propres indisponibles, ajust\u00E9 \u00E0 1.017.715.815,97 EUR.",
      "new_text": "La soci\u00E9t\u00E9 dispose de capitaux propres dont un montant de un milliard dix-sept millions sept cent quinze mille huit cent quinze euros nonante-sept cents (1.017.715.815,97 EUR) est indisponible.",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5"
    }
  ],
  "governance_change": {
    "organ_kind_after": null,
    "organ_kind_before": null,
    "admin_delegated_added": [
      {
        "name": "Samuel WYNANT",
        "excluded_powers": []
      }
    ],
    "representation_rule_after": null,
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel WYNANT",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition",
    "procuration",
    "statuts coordonn\u00E9s"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "wvv_capital_release"
    ],
    "split_ratio": null,
    "shares_after": null,
    "shares_before": null,
    "capital_after_eur": null,
    "capital_before_eur": null,
    "share_classes_after": []
  },
  "coordinated_text_lineage": {
    "previous_ag_date": "2025-04-28",
    "previous_mb_reference": null
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-12-23",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB Biopharma"
  }
}

{
  "events": [
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Ann Gudiens",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "Conform\u00E9ment aux statuts de la Soci\u00E9t\u00E9, les pouvoirs sp\u00E9ciaux suivants ont \u00E9t\u00E9 d\u00E9l\u00E9gu\u00E9s: RELATIVEMENT AUX RESSOURCES HUMAINES: En mati\u00E8re d\u0027emploi, y compris pour la signature des contrats de travail individuels, le r\u00E8glement des contrats de travail, les d\u00E9parts et plus g\u00E9n\u00E9ralement, tous les docume",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Bram De Pooter",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "b) Bram De Pooter, signataire obligatoire pour l\u0027approbation de la paie et pour les accords de sortie des cadres jusqu\u0027au niveau SMI, avec une indemnit\u00E9 de d\u00E9part entre 0,5 et 1,0 million d\u0027euros:",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Alexandra Nijssen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "c) Alexandra Nijssen, signataire obligatoire pour l\u0027approbation de la paie et pour les accords de sortie des cadres jusqu\u0027au niveau SMI avec une indemnit\u00E9 de d\u00E9part jusqu\u0027\u00E0 0,5 million d\u0027euros;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Laetitia Munoko",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "d) Laetitia Munoko, Natascha Tassier, Lo\u00EFc Petit, Blerta Aliaj, Olivier Bruneel, S\u00E9bastien Lair et Anke Sanders pour toutes les autres lettres d\u0027intention et contrats de travail, y compris les avenants et les certifications.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Natascha Tassier",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "d) Laetitia Munoko, Natascha Tassier, Lo\u00EFc Petit, Blerta Aliaj, Olivier Bruneel, S\u00E9bastien Lair et Anke Sanders pour toutes les autres lettres d\u0027intention et contrats de travail, y compris les avenants et les certifications.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Lo\u00EFc Petit",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "d) Laetitia Munoko, Natascha Tassier, Lo\u00EFc Petit, Blerta Aliaj, Olivier Bruneel, S\u00E9bastien Lair et Anke Sanders pour toutes les autres lettres d\u0027intention et contrats de travail, y compris les avenants et les certifications.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Blerta Aliaj",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "d) Laetitia Munoko, Natascha Tassier, Lo\u00EFc Petit, Blerta Aliaj, Olivier Bruneel, S\u00E9bastien Lair et Anke Sanders pour toutes les autres lettres d\u0027intention et contrats de travail, y compris les avenants et les certifications.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Olivier Bruneel",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "d) Laetitia Munoko, Natascha Tassier, Lo\u00EFc Petit, Blerta Aliaj, Olivier Bruneel, S\u00E9bastien Lair et Anke Sanders pour toutes les autres lettres d\u0027intention et contrats de travail, y compris les avenants et les certifications.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "S\u00E9bastien Lair",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "d) Laetitia Munoko, Natascha Tassier, Lo\u00EFc Petit, Blerta Aliaj, Olivier Bruneel, S\u00E9bastien Lair et Anke Sanders pour toutes les autres lettres d\u0027intention et contrats de travail, y compris les avenants et les certifications.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Anke Sanders",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "d) Laetitia Munoko, Natascha Tassier, Lo\u00EFc Petit, Blerta Aliaj, Olivier Bruneel, S\u00E9bastien Lair et Anke Sanders pour toutes les autres lettres d\u0027intention et contrats de travail, y compris les avenants et les certifications.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Laurent Simonart",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "En ce qui concerne la signature des conventions collectives de travail, la Soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e par chac\u00FAne des personnes suivantes, agissant conjointement deux \u00E0 deux: - Laurent Simonart;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Sylvie Rauel-Rasmussen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "En ce qui concerne la signature des conventions collectives de travail, la Soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e par chac\u00FAne des personnes suivantes, agissant conjointement deux \u00E0 deux: - Laurent Simonart; - Alexandra Nijssen; - Sylvie Rauel-Rasmussen (pour le site HQ) ou Myriam Juckler (pour le site ",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Myriam Juckler",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "En ce qui concerne la signature des conventions collectives de travail, la Soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e par chac\u00FAne des personnes suivantes, agissant conjointement deux \u00E0 deux: - Laurent Simonart; - Alexandra Nijssen; - Sylvie Rauel-Rasmussen (pour le site HQ) ou Myriam Juckler (pour le site ",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Philip Vanstraelen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT A LA FISCALITE En ce qui concerne tous les d\u0117p\u00F4ts et enregistrements, modifications de d\u00E9p\u00F4ts et d\u0027enregistrements, immatriculations et annulation d\u0022immatriculations, aupr\u00E8s de toutes les autorit\u00E9s fiscales, au niveau belge, europ\u00E9en, international ou \u00E9tranger, y compris la signature de",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Dennis Beyers",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "R\u00E9serv\u00E9 au Moniteur belge Bijlage bij het Belgisch Staatsblad - 02/10/2025 - Annexes du Moniteur belge - Dennis Beyers;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Aur\u00E9lie Saint-Amand",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "R\u00E9serv\u00E9 au Moniteur belge Bijlage bij het Belgisch Staatsblad - 02/10/2025 - Annexes du Moniteur belge - Aur\u00E9lie Saint-Amand;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Lydia Sauveni\u00E8re",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "R\u00E9serv\u00E9 au Moniteur belge Bijlage bij het Belgisch Staatsblad - 02/10/2025 - Annexes du Moniteur belge - Lydia Sauveni\u00E8re;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Caroline Vancoillie",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "R\u00E9serv\u00E9 au Moniteur belge Bijlage bij het Belgisch Staatsblad - 02/10/2025 - Annexes du Moniteur belge - Caroline Vancoillie.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Xavier Michel",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT AUX MANDATS: Concernant les mandats de la Soci\u00E9t\u00E9 en tant qu\u0027associ\u00E9e, membre, administrateur, liquidateur ou \u00E0 un autre titre au sein d\u0027une autre personne morale, association, soci\u00E9t\u00E9 ou groupement dont l\u0027objet social est li\u00E9, similaire ou participant \u00E0 la r\u00E9alisation de l\u0027objet social",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Valentijn Peeters",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT AUX MANDATS: Concernant les mandats de la Soci\u00E9t\u00E9 en tant qu\u0027associ\u00E9e, membre, administrateur, liquidateur ou \u00E0 un autre titre au sein d\u0027une autre personne morale, association, soci\u00E9t\u00E9 ou groupement dont l\u0027objet social est li\u00E9, similaire ou participant \u00E0 la r\u00E9alisation de l\u0027objet social",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Davina Devleeschouwer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT AUX MANDATS: Concernant les mandats de la Soci\u00E9t\u00E9 en tant qu\u0027associ\u00E9e, membre, administrateur, liquidateur ou \u00E0 un autre titre au sein d\u0027une autre personne morale, association, soci\u00E9t\u00E9 ou groupement dont l\u0027objet social est li\u00E9, similaire ou participant \u00E0 la r\u00E9alisation de l\u0027objet social",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Xavier Michel",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT AUX PARTICIPATIONS: Concernant l\u0027exercice de tous les droits li\u00E9s aux actions et autres titres d\u00E9tenus par la Soci\u00E9t\u00E9, y compris, mais sans s\u0027y limiter, les droits de vote aux assembl\u00E9es g\u00E9n\u00E9rales ordinaires, sp\u00E9ciales ou extraordinaires, les droits en vertu de pactes d\u0027actionnaires, de",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Valentijn Peeters",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT AUX PARTICIPATIONS: Concernant l\u0027exercice de tous les droits li\u00E9s aux actions et autres titres d\u00E9tenus par la Soci\u00E9t\u00E9, y compris, mais sans s\u0027y limiter, les droits de vote aux assembl\u00E9es g\u00E9n\u00E9rales ordinaires, sp\u00E9ciales ou extraordinaires, les droits en vertu de pactes d\u0027actionnaires, de",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Davina Devleeschouwer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT AUX PARTICIPATIONS: Concernant l\u0027exercice de tous les droits li\u00E9s aux actions et autres titres d\u00E9tenus par la Soci\u00E9t\u00E9, y compris, mais sans s\u0027y limiter, les droits de vote aux assembl\u00E9es g\u00E9n\u00E9rales ordinaires, sp\u00E9ciales ou extraordinaires, les droits en vertu de pactes d\u0027actionnaires, de",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Xavier Michel",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT \u00C0 L\u0027IMMOBILIER: Concernant toutes les actions juridiques relatives \u00E0 l\u0027immobilier, y compris (i) l\u0027achat et la vente, les accords d\u0027\u00E9change, le bail, le leasing, le leasing immobilier, le bail emphyt\u00E9otique, la renonciation au droit d\u0027accession, les permis de construire, la copropri\u00E9t\u00E9,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Valentijn Peeters",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT \u00C0 L\u0027IMMOBILIER: Concernant toutes les actions juridiques relatives \u00E0 l\u0027immobilier, y compris (i) l\u0027achat et la vente, les accords d\u0027\u00E9change, le bail, le leasing, le leasing immobilier, le bail emphyt\u00E9otique, la renonciation au droit d\u0027accession, les permis de construire, la copropri\u00E9t\u00E9,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Davina Devleeschouwer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT \u00C0 L\u0027IMMOBILIER: Concernant toutes les actions juridiques relatives \u00E0 l\u0027immobilier, y compris (i) l\u0027achat et la vente, les accords d\u0027\u00E9change, le bail, le leasing, le leasing immobilier, le bail emphyt\u00E9otique, la renonciation au droit d\u0027accession, les permis de construire, la copropri\u00E9t\u00E9,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Dominique Lecocq",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIVEMENT \u00C0 L\u0027IMMOBILIER: Concernant toutes les actions juridiques relatives \u00E0 l\u0027immobilier, y compris (i) l\u0027achat et la vente, les accords d\u0027\u00E9change, le bail, le leasing, le leasing immobilier, le bail emphyt\u00E9otique, la renonciation au droit d\u0027accession, les permis de construire, la copropri\u00E9t\u00E9,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Xavier Michel",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIF AUX DEPOTS ET PUBLICATIONS: En ce qui concerne l\u0027inscription, les \u00E9ventuelles modifications ou radiations aupr\u00E8s de la Banque Carrefour des Entreprises, le registre UBO, les d\u00E9p\u00F4ts aupr\u00E9s du greffe comp\u00E9tent et toute publication au Moniteur belge, la Soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e par c",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Valentijn Peeters",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIF AUX DEPOTS ET PUBLICATIONS: En ce qui concerne l\u0027inscription, les \u00E9ventuelles modifications ou radiations aupr\u00E8s de la Banque Carrefour des Entreprises, le registre UBO, les d\u00E9p\u00F4ts aupr\u00E9s du greffe comp\u00E9tent et toute publication au Moniteur belge, la Soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e par c",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Davina Devleeschouwer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIF AUX DEPOTS ET PUBLICATIONS: En ce qui concerne l\u0027inscription, les \u00E9ventuelles modifications ou radiations aupr\u00E8s de la Banque Carrefour des Entreprises, le registre UBO, les d\u00E9p\u00F4ts aupr\u00E9s du greffe comp\u00E9tent et toute publication au Moniteur belge, la Soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e par c",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Dominique Lecocq",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "RELATIF AUX DEPOTS ET PUBLICATIONS: En ce qui concerne l\u0027inscription, les \u00E9ventuelles modifications ou radiations aupr\u00E8s de la Banque Carrefour des Entreprises, le registre UBO, les d\u00E9p\u00F4ts aupr\u00E9s du greffe comp\u00E9tent et toute publication au Moniteur belge, la Soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e par c",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Xavier Michel",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "ET (ii) de donner mandat \u00E0 chaque administrateur, au Secr\u00E9taire G\u00E9n\u00E9ral du Groupe Xavier Michel,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Valentijn Peeters",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "ET (ii) de donner mandat \u00E0 chaque administrateur, au Secr\u00E9taire G\u00E9n\u00E9ral du Groupe Xavier Michel, Valentijn Peeters,",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Davina Devleeschouwer",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "ET (ii) de donner mandat \u00E0 chaque administrateur, au Secr\u00E9taire G\u00E9n\u00E9ral du Groupe Xavier Michel, Valentijn Peeters, Davina Devleeschouwer",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Dominique Lecocq",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "ET (ii) de donner mandat \u00E0 chaque administrateur, au Secr\u00E9taire G\u00E9n\u00E9ral du Groupe Xavier Michel, Valentijn Peeters, Davina Devleeschouwer et Dominique Lecocq, chacun agissant seul, avec facult\u00E9 de sub-d\u00E9l\u00E9gation :",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "directeur",
      "person": {
        "rrn": null,
        "name": "Dominique Lecocq",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-03-26",
      "evidence_quote": "Ces pouvoirs sp\u00E9ciaux effectifs au 26 mars 2025 sont r\u00E9gis par le droit belge et sont valables jusqu\u0027\u00E0 ce qu\u0027ils soient r\u00E9voqu\u00E9s.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-10-02",
    "filing_date": "2025-09-25",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "conseil_d_administration",
      "date": "2025-03-26",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB Biopharma",
    "legal_form": "SRL"
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "stage": null,
  "notary": {
    "name": "Philip Van Nevel",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-06-11",
    "filing_date": "2025-06-03",
    "act_kind_objet": "All\u00E9e de la Recherche 60 - 1070 Bruxelles (Anderlecht)"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2025-05-26",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0543.573.053",
        "name": "UCB Biopharma",
        "role": "other",
        "address": "All\u00E9e de la Recherche 60 - 1070 Bruxelles (Anderlecht)",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "2:8 \u00A74"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Aucun transfert de patrimoine n\u0027est effectu\u00E9. L\u0027acte concerne la communication du d\u00E9p\u00F4t des r\u00E9solutions \u00E9crites des administrateurs, qui constatent que toutes les actions de la soci\u00E9t\u00E9 sont d\u00E9tenues par un seul actionnaire.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB Biopharma",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Philip Van Nevel",
    "org_rep_person_name": null
  },
  "summary_narrative": "Les administrateurs de UCB Biopharma, soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e, ont adopt\u00E9 des r\u00E9solutions \u00E9crites unanimes le 26 mai 2025, confirmant que toutes les actions de la soci\u00E9t\u00E9 sont d\u00E9tenues par un seul actionnaire. Ces r\u00E9solutions ont \u00E9t\u00E9 d\u00E9pos\u00E9es au greffe du tribunal de l\u0027entreprise francophone de Bruxelles le 3 juin 2025, conform\u00E9ment \u00E0 l\u0027article 2:8 \u00A74 du Code des soci\u00E9t\u00E9s et associations.",
  "co_filed_documents": [
    "R\u00E9solutions \u00E9crites des administrateurs de la soci\u00E9t\u00E9 du 26 mai 2025"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "stage": null,
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-06-11",
    "filing_date": "2025-06-03",
    "act_kind_objet": "All\u00E9e de la Recherche 60 - 1070 Bruxelles (Anderlecht)"
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "act_date": "2025-05-26",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": null,
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB Biopharma",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Philip Van Nevel",
    "org_rep_person_name": null
  },
  "summary_narrative": "This act is a communication of deposit to the company\u0027s file, pursuant to article 2:8 \u00A74 of the Code of Companies and Associations. It records the unanimous written resolutions of the administrators dated May 26, 2025, which acknowledged that all shares of the company are held by a single person, as well as the identity of the sole shareholder. The act also grants a special power of attorney to several individuals and lawyers from Freshfields Bruckhaus Deringer LLP to handle the formalities related to the publication of the preceding resolutions.",
  "co_filed_documents": [
    "R\u00E9solutions \u00E9crites des administrateurs de la soci\u00E9t\u00E9 du 26 mai 2025"
  ],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-05-01",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "Le commissaire, la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB Forvis Mazars R\u00E9viseurs d\u0027Entreprises \u00BB, repr\u00E9sent\u00E9e par Monsieur S\u00E9bastien Schueremans, r\u00E9viseur d\u2019entreprises, a \u00E9tabli un rapport \u00E9crit sur le projet de scission partielle en application de l\u2019article 12:62 du Code des soci\u00E9t\u00E9s et des associations.",
    "firm_kbo": null,
    "firm_name": "Forvis Mazars R\u00E9viseurs d\u0027Entreprises",
    "ibr_number": null,
    "individual_name": "S\u00E9bastien Schueremans"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": true
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "old": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "changed": false
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Matthieu DERYNCK",
    "firm_city": null,
    "firm_name": "Van Halteren Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-05-12",
    "filing_date": "2025-05-08",
    "act_kind_objet": "DIVERS, STATUTS (TRADUCTION, COORDINATION, AUTRES"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2025-04-28",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "demerger_partial",
  "report_waiver": {
    "summary": "Les actionnaires ont renonc\u00E9 au d\u00E9lai d\u2019un mois pr\u00E9vu \u00E0 l\u2019article 12:64 du Code des soci\u00E9t\u00E9s et des associations, ainsi qu\u2019\u00E0 l\u2019\u00E9tablissement d\u2019un \u00E9tat comptable interm\u00E9diaire et \u00E0 la mention d\u2019\u00E9ventuelles modifications importantes du patrimoine depuis le projet de scission.",
    "articles": [
      "12:64"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0543.573.053",
        "name": "UCB BIOPHARMA",
        "role": "demerged",
        "address": "All\u00E9e de la Recherche 60, 1070 Anderlecht",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "UCB DEVELOPED BRANDS",
        "role": "recipient",
        "address": null,
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": 1.0,
    "legal_articles": [
      "12:59",
      "12:60",
      "12:61",
      "12:62",
      "12:63",
      "12:64",
      "12:7",
      "12:8",
      "12:4"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2024-12-31",
    "exchange_ratio_text": "1 action UCB Developed Brands SRL \u00E9mise pour 1 action UCB Biopharma SRL",
    "new_shares_issued_n": 32383629,
    "real_estate_included": false,
    "patrimony_description": "Le transfert concerne le portfolio de m\u00E9dicaments matures d\u0027UCB Biopharma, comprenant notamment Cimzia\u00AE, Keppra\u00AE et Briviact\u00AE, ainsi que les droits de propri\u00E9t\u00E9 intellectuelle, les frais de R\u0026D, les cr\u00E9dits d\u0027imp\u00F4t R\u0026D, les contrats de travail des employ\u00E9s transf\u00E9r\u00E9s, et les obligations li\u00E9es \u00E0 ces employ\u00E9s. Les actifs et passifs non express\u00E9ment attribu\u00E9s restent la propri\u00E9t\u00E9 d\u0027UCB Biopharma.",
    "equity_transferred_eur": 72309112.0,
    "accounting_effective_date": "2025-05-01"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel WYNANT",
    "org_rep_person_name": null
  },
  "summary_narrative": "Le 28 avril 2025, une assembl\u00E9e g\u00E9n\u00E9rale d\u0027UCB BIOPHARMA a approuv\u00E9 une scission partielle par apport \u00E0 UCB DEVELOPED BRANDS de son portfolio de m\u00E9dicaments matures, incluant des marques comme Cimzia\u00AE, Keppra\u00AE et Briviact\u00AE, ainsi que les droits de propri\u00E9t\u00E9 intellectuelle, les frais de R\u0026D et les contrats de travail des employ\u00E9s transf\u00E9r\u00E9s. L\u0027op\u00E9ration, effective \u00E0 minuit le 1er mai 2025, a \u00E9t\u00E9 int\u00E9gralement r\u00E9mun\u00E9r\u00E9e par l\u0027\u00E9mission de 32 383 629 actions d\u0027UCB DEVELOPED BRANDS aux actionnaires d\u0027UCB BIOPHARMA, et a entra\u00EEn\u00E9 une r\u00E9duction provisoire des capitaux propres indisponibles de 72 309 ",
  "co_filed_documents": [
    "exp\u00E9dition",
    "procurations",
    "rapports"
  ],
  "detected_real_type": "demerger_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "notary": {
    "name": "Matthieu DERYNCK",
    "firm_city": null,
    "firm_name": "Van Halteren Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-05-12",
    "filing_date": "2025-05-08",
    "act_kind_objet": "DIVERS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "act_date": "2025-05-01",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "translation_only",
    "trigger": "form_change_consequence",
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": {
    "firm_kbo": null,
    "firm_name": "Forvis Mazars R\u00E9viseurs d\u0027Entreprises",
    "ibr_number": null,
    "individual_name": "S\u00E9bastien Schueremans"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full_after": null,
    "legal_form_after": null,
    "name_full_before": "UCB BIOPHARMA",
    "current_zetel_raw": "All\u00E9e de la Recherche 60, 1070 Anderlecht",
    "legal_form_before": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "Matthieu Derynck",
      "scope_categories": [
        "statuts"
      ],
      "with_substitution": false
    },
    {
      "holder_kbo": null,
      "holder_name": "tous autres notaires belges",
      "scope_categories": [
        "statuts"
      ],
      "with_substitution": false
    },
    {
      "holder_kbo": null,
      "holder_name": "tous employ\u00E9s de l\u2019\u00E9tude des notaires \u00AB Van Halteren Notaires \u00BB",
      "scope_categories": [
        "statuts"
      ],
      "with_substitution": false
    },
    {
      "holder_kbo": null,
      "holder_name": "chaque administrateur d\u2019UCB BIOPHARMA",
      "scope_categories": [
        "statuts"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "Remplacement du premier paragraphe de l\u0027article 5 des statuts par un texte pr\u00E9cisant un montant de capitaux propres indisponibles de 1.021.088.895 EUR.",
      "new_text": "La soci\u00E9t\u00E9 dispose de capitaux propres dont un montant d\u2019un milliard vingt et un millions quatre-vingt-huit mille huit cent nonante-cinq euros (1.021.088.895 EUR) est indisponible.",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5"
    }
  ],
  "governance_change": {
    "organ_kind_after": null,
    "organ_kind_before": null,
    "admin_delegated_added": [
      {
        "name": "Matthieu Derynck",
        "excluded_powers": []
      },
      {
        "name": "tous autres notaires belges",
        "excluded_powers": []
      },
      {
        "name": "tous employ\u00E9s de l\u2019\u00E9tude des notaires \u00AB Van Halteren Notaires \u00BB",
        "excluded_powers": []
      },
      {
        "name": "chaque administrateur d\u2019UCB BIOPHARMA",
        "excluded_powers": []
      }
    ],
    "representation_rule_after": null,
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel WYNANT",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition",
    "procurations",
    "rapports"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "wvv_capital_release"
    ],
    "split_ratio": null,
    "shares_after": null,
    "shares_before": null,
    "capital_after_eur": null,
    "capital_before_eur": null,
    "share_classes_after": []
  },
  "coordinated_text_lineage": null
}

{
  "stage": null,
  "notary": {
    "name": "Samuel Wynant",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-03-18",
    "filing_date": "2025-03-14",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-03-14",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0543.573.053",
        "name": "UCB BIOPHARMA",
        "role": "demerged",
        "address": "All\u00E9e de la Recherche 60, 1070 Anderlecht",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "1017.533.562",
        "name": "UCB DEVELOPED BRANDS",
        "role": "recipient",
        "address": "All\u00E9e de la Recherche 60, 1070 Anderlecht",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": 1.0,
    "legal_articles": [
      "12:8",
      "12:4",
      "12:59",
      "12:67",
      "12:69"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2024-12-31",
    "exchange_ratio_text": "1 action pour 1 action",
    "new_shares_issued_n": 32383629,
    "real_estate_included": false,
    "patrimony_description": "Le patrimoine transf\u00E9r\u00E9 comprend les droits de propri\u00E9t\u00E9 intellectuelle, les frais de recherche et d\u00E9veloppement (R\u0026D), les cr\u00E9dits d\u0027imp\u00F4t R\u0026D, ainsi que les contrats de travail des employ\u00E9s transf\u00E9r\u00E9s li\u00E9s au portefeuille mature. Les passifs associ\u00E9s aux employ\u00E9s transf\u00E9r\u00E9s sont \u00E9galement transf\u00E9r\u00E9s.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2025-05-01"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "detected_kind_raw": "parti\u00EBle splitsing",
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Freshfields LLP",
    "person_name": null,
    "org_rep_person_name": "Dennis Beyers, Aur\u00E9lie Saint-Amand, Valentijn Peeters, Dominique Lecocq, Deborah Janssens, Elliott Foss\u00E9prez, Guillaume Nelis, Els De Troyer, Philip Van Nevel, Matthieu Derynck, Anne-Catherine Guiot"
  },
  "summary_narrative": "Le projet de scission partielle de UCB Biopharma pr\u00E9voit le transfert des actifs et passifs li\u00E9s \u00E0 son portefeuille de m\u00E9dicaments matures, notamment Cimzia\u00AE, Keppra\u00AE et Briviact\u00AE, \u00E0 UCB Developed Brands. Cette op\u00E9ration, approuv\u00E9e par les conseils d\u0027administration des deux soci\u00E9t\u00E9s, sera soumise \u00E0 l\u0027approbation des assembl\u00E9es g\u00E9n\u00E9rales extraordinaires pr\u00E9vues pour le 28 avril 2025. \u00C0 compter du 1er mai 2025, UCB Developed Brands \u00E9mettra une action ordinaire pour chaque action existante de UCB Biopharma, sans contrepartie en esp\u00E8ces.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-12-10",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "notary": {
    "name": "Matthieu DERYNCK",
    "firm_city": null,
    "firm_name": "Van Halteren, Notaires Associ\u00E9s",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-01-02",
    "filing_date": "2024-12-29",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-12-10",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment",
      "legal_form_change",
      "wvv_adaptation"
    ],
    "scope": "full_restatement",
    "trigger": "wvv_adaptation",
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full_after": null,
    "legal_form_after": null,
    "name_full_before": "UCB BIOPHARMA",
    "current_zetel_raw": "All\u00E9e de la Recherche 60, 1070 Anderlecht",
    "legal_form_before": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "Van Halteren Notaires",
      "scope_categories": [
        "publication"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "The assembly renounces the reports prescribed by article 5:121 \u00A7 1 of the Code of companies and associations.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5:121 \u00A7 1"
    },
    {
      "summary": "The assembly increases the company\u0027s own funds by a cash contribution of 800,000,000 EUR without issuing new shares.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5:120, \u00A72"
    },
    {
      "summary": "The first paragraph of article 5 is replaced with a new text stating the amount of unavailable own funds.",
      "new_text": "La soci\u00E9t\u00E9 dispose de capitaux propres dont un montant de trois milliards cinq cent nonante-quatre millions neuf cent soixante-neuf mille trente-deux euros deux cents ( 3.594.969.032,02 EUR)) est indisponible",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5"
    },
    {
      "summary": "The first paragraph of article 5 is replaced with a new text stating the reduced amount of unavailable own funds.",
      "new_text": "La soci\u00E9t\u00E9 dispose de capitaux propres dont un montant d\u2019un milliard nonante-trois millions trois cent nonante-huit mille sept (1.093.398.007) est indisponible.",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5"
    }
  ],
  "governance_change": {
    "organ_kind_after": null,
    "organ_kind_before": null,
    "admin_delegated_added": [],
    "representation_rule_after": null,
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel WYNANT",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition",
    "procurations",
    "attestation bancaire"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_cash",
      "wvv_capital_release"
    ],
    "split_ratio": null,
    "shares_after": null,
    "shares_before": null,
    "capital_after_eur": 1093398007.0,
    "capital_before_eur": 3594969032.02,
    "share_classes_after": []
  },
  "coordinated_text_lineage": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "old": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Dhavalkumar Patel",
        "address": "All\u00E9e de la Recherche, 60 \u00E0 1070 Anderlecht (Bruxelles)",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": "2024-07-01",
      "evidence_quote": "d\u0027accepter la d\u00E9mission de M. Dhavalkumar (connu sous le nom \u003C Dhaval \u00BB) Patel, avec adresse professionnelle All\u00E9e de la Recherche, 60 \u00E0 1070 Anderlecht (Bruxelles), en qualit\u00E9 d\u0027administrateur de la soci\u00E9t\u00E9 avec effet au 1 juillet 2024.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Alistair Henry",
        "address": "All\u00E9e de la Recherche, 60 \u00E0 1070 Anderlecht (Bruxelles)",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "de nommer M. Alistair Henry, avec adresse professionelle All\u00E9e de la Recherche, 60 \u00E0 1070 Anderlecht (Bruxelles), avec effet imm\u00E9diat, en qualit\u00E9 de nouvel administrateur pour une dur\u00E9e intermin\u00E9e.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "commissaris_in",
      "role": "commissaire",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Mazars Bedrijfsrevisoren - R\u00E9viseurs d\u0027Entreprises BV/SRL",
        "address": null,
        "country": null,
        "legal_form": "BV/SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "de nommer Mazars Bedrijfsrevisoren - R\u00E9viseurs d\u0027Entreprises BV/SRL, commissaire aux comptes, dont le mandat expire \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de 2024 pour une dur\u00E9e de 3 ans, jusqu\u0027\u00E0 et y compris l\u0027assembl\u00E9e g\u00E9n\u00E9rale annuelle de 2027 (convoqu\u00E9e pour statuer sur les comptes a",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2027"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "rep_rotation",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "S\u00E9bastien Schueremans",
        "address": null,
        "birth_date": null,
        "profession": "r\u00E9viseur d\u0027entreprises",
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Mazars Bedrijfsrevisoren - R\u00E9viseurs d\u0027Entreprises BV/SRL",
        "address": null,
        "country": null,
        "legal_form": "BV/SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le repr\u00E9sentant permanent de Mazars Bedrijfsrevisoren - R\u00E9viseurs d\u0027Entreprises BV/SRL pour l\u0027ex\u00E9cution de ce mandat d\u0027audit est M. S\u00E9bastien Schueremans, r\u00E9viseur d\u0027entreprises.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-07-18",
    "filing_date": "2024-06-24",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2024-06-24",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB Biopharma",
    "legal_form": "SRL"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Dominique Lecocq",
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Dhavalkumar (connu sous le nom \u003CDhaval\u003E) Patel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Alistair Henry",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire aux comptes",
      "person": {
        "rrn": null,
        "name": "Mazars Bedrijfsrevisoren - R\u00E9viseurs d\u0027Entreprises BV/SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "r\u00E9viseur d\u0027entreprises (repr\u00E9sentant permanent du commissaire)",
      "person": {
        "rrn": null,
        "name": "S\u00E9bastien Schueremans",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB Biopharma"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Patel, Dhavalkumar",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-07-01",
      "evidence_quote": "d\u0027accepter la d\u00E9mission de M. Dhavalkumar (connu sous le nom \u003C Dhaval \u00BB) Patel, avec adresse professionelle All\u00E9e de la Recherche, 60 \u00E0 1070 Anderlecht (Bruxelles), en qualit\u00E9 d\u0027administrateur de la soci\u00E9t\u00E9 avec effet au 1 juillet 2024."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Henry, Alistair",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-06-24",
      "evidence_quote": "de nommer M. Alistair Henry, avec adresse professionelle All\u00E9e de la Recherche, 60 \u00E0 1070 Anderlecht (Bruxelles), avec effet imm\u00E9diat, en qualit\u00E9 de nouvel administrateur pour une dur\u00E9e intermin\u00E9e."
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Schueremans, S\u00E9bastien",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Mazars Bedrijfsrevisoren - R\u00E9viseurs d\u0027Entreprises BV/SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-06-24",
      "evidence_quote": "de nommer Mazars Bedrijfsrevisoren - R\u00E9viseurs d\u0027Entreprises BV/SRL, commissaire aux comptes, dont le mandat expire \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de 2024 pour une dur\u00E9e de 3 ans, jusqu\u0027\u00E0 et y compris l\u0027assembl\u00E9e g\u00E9n\u00E9rale annuelle de 2027 (convoqu\u00E9e pour statuer sur les comptes a"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Ann Gudiens",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Bram De Pooter",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Alexandra Nijssen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Jessica Pierre",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Olivier Bruneel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Blerta Aliaj",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Laetitia Munoko Mubolo",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Natacha Tassier",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Laurent Simonart",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Sylvie Rauel-Rasmussen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Geoffroy Folie",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Emmanuelle Senior",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Dennis Beyers",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Xavier Michel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Valentijn Peeters",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Florence Andrianne",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "signatory",
      "person": {
        "rrn": null,
        "name": "Dominique Lecocq",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB Biopharma"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "William Silbey",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-31",
      "evidence_quote": "Les Actionnaires, \u00E0 l\u0027unanimit\u00E9, actent la d\u00E9mission de William Silbey, avec adresse professionelle All\u00E9e de la Recherche, 60 \u00E0 1070 Anderlecht (Bruxelles), en qualit\u00E9 d\u0027administrateur avec effet au 31 mars 2023."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Denelle J. Waynick Johnson",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-01",
      "evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 5:85 du Code des soci\u00E9t\u00E9s et associations, les Actionnaires d\u00E9cident \u00E0 l\u0027unanimit\u00E9 de ratifier la nomination de Denelle J. Waynick Johnson, avec adresse professionelle All\u00E9e de la Recherche, 60 \u00E0 1070 Anderlecht (Bruxelles), en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9 avec eff"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "William Silbey",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Denelle J. Waynick Johnson",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB Biopharma"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2022-07-15",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "Le commissaire, la soci\u00E9t\u00E9 \u0022Mazars R\u00E9viseurs d\u2019Entreprises\u0022 SRL, repr\u00E9sent\u00E9e par Monsieur Anton NUTTENS Anthony, r\u00E9viseur d\u0027entreprises, a \u00E9tabli un rapport sur l\u0027apport projet\u00E9... pour laquelle nous avons \u00E9t\u00E9 d\u00E9sign\u00E9s par lettre de mission du 4 juillet 2022.",
    "firm_kbo": null,
    "firm_name": "Mazars R\u00E9viseurs d\u2019Entreprises SRL",
    "ibr_number": null,
    "individual_name": "Anton NUTTENS Anthony"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 2794969032.02,
      "delta_eur": 1241527033.59,
      "before_eur": 1553441998.43,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 819225268.29,
      "delta_eur": 819225268.29,
      "before_eur": 0.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "UCB PHARMA",
          "share_class": null,
          "liberation_pct": 100.0,
          "contribution_kind": "natura",
          "n_shares_subscribed": 16968535,
          "contribution_amount_eur": 819225268.29
        }
      ],
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": 16968535,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "natura",
      "paid_up_delta_eur": 819225268.29,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    },
    {
      "kind": "capital_increase",
      "after_eur": 180774731.71,
      "delta_eur": 180774731.71,
      "before_eur": 0.0,
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": 3744370,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 180774731.71,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    },
    {
      "kind": "statutory_reserve_release",
      "after_eur": null,
      "delta_eur": -1231517238.43,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": 32383629,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Samuel WYNANT",
    "firm_city": null,
    "firm_name": "Van Halteren, notaires associ\u00E9s",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-07-28",
    "filing_date": "2022-07-26",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2022-07-15",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "MAZARS R\u00C9VISEURS D\u0027ENTREPRISES SRL",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Anton NUTTENS Anthony"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition",
    "procurations",
    "rapports",
    "attestation bancaire",
    "coordination des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 819225268.29,
      "currency": "EUR",
      "after_eur": 2794969032.02,
      "delta_eur": 819225268.29,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2022-07-15",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter un premier apport \u00E0 concurrence d\u2019un montant de 819.225.268,29 EUR, r\u00E9mun\u00E9r\u00E9 par l\u2019\u00E9mission de 16.968.535 nouvelles actions... Ces actions nouvelles seront attribu\u00E9es, enti\u00E8rement lib\u00E9r\u00E9es, \u00E0 la soci\u00E9t\u00E9 anonyme UCB PHARMA, en r\u00E9mun\u00E9ration de l\u0027apport en nature par cette derni\u00E8re de la note intra-groupe d\u2019un montant total de 819.225.268,29 EUR au 15 juillet 2022",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_increase",
      "amount": 180774731.71,
      "currency": "EUR",
      "after_eur": 2794969032.02,
      "delta_eur": 180774731.71,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2022-07-15",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter un second apport \u00E0 concurrence d\u2019un montant de 180.774.731,71 EUR, r\u00E9mun\u00E9r\u00E9 par l\u2019\u00E9mission de 3.744.370 nouvelles actions... Ces actions nouvelles seront souscrites pour le montant total de 180.774.731,71 EUR et int\u00E9gralement lib\u00E9r\u00E9es en esp\u00E8ces lors de la souscription.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "old": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "changed": false
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Samuel WYNANT",
    "firm_city": null,
    "firm_name": "Van Halteren, Notaires Associ\u00E9s",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2021-07-19",
    "filing_date": "2021-07-01",
    "act_kind_objet": "Objet de l\u0027acte: R\u00C9UNION DE TOUTES LES ACTIONS EN UNE SEULE MAIN - FUSION"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2021-07-01",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0543.573.053",
        "name": "UCB BIOPHARMA SRL",
        "role": "absorbed",
        "address": "Anderlecht (1070 Bruxelles), all\u00E9e de la Recherche 60",
        "is_foreign": false,
        "legal_form": "SRL",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0543.573.053",
        "name": "HANDL THERAPEUTICS SRL",
        "role": "acquiring",
        "address": "3001 Leuven, Gaston Geenslaan 1",
        "is_foreign": false,
        "legal_form": "SRL",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:2"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027int\u00E9gralit\u00E9 du patrimoine de HANDL THERAPEUTICS SRL, y compris tous les droits de propri\u00E9t\u00E9 intellectuelle, les brevets, les savoir-faire, marques, logiciels, bases de donn\u00E9es, mat\u00E9riaux biologiques et informations confidentielles, est transf\u00E9r\u00E9e \u00E0 UCB BIOPHARMA SRL.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2021-01-01"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA",
    "legal_form": "SRL"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Samuel WYNANT",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de UCB BIOPHARMA SRL, r\u00E9unie le 1er juillet 2021, a d\u00E9cid\u00E9 la fusion par absorption de la soci\u00E9t\u00E9 par HANDL THERAPEUTICS SRL, par transfert int\u00E9gral de son patrimoine. Cette fusion, fond\u00E9e sur l\u0027article 12:2 du Code des soci\u00E9t\u00E9s et des associations, inclut tous les droits de propri\u00E9t\u00E9 intellectuelle, brevets, savoir-faire, marques, logiciels, bases de donn\u00E9es, mat\u00E9riaux et informations confidentielles. L\u0027op\u00E9ration est comptablement effective \u00E0 compter du 1er janvier 2021.",
  "co_filed_documents": [
    "exp\u00E9dition"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0543.573.053",
    "name_full": "UCB BIOPHARMA"
  }
}